Dhanuka Agritech Toekomstige groei
Future criteriumcontroles 2/6
Dhanuka Agritech zal naar verwachting groeien in winst en omzet met respectievelijk 10.4% en 11.7% per jaar. De winst per aandeel zal naar verwachting groeien met 10.7% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 16.5% zijn.
Belangrijke informatie
10.4%
Groei van de winst
10.69%
Groei van de winst per aandeel
| Chemicals winstgroei | 18.4% |
| Inkomstengroei | 11.7% |
| Toekomstig rendement op eigen vermogen | 16.45% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 25 May 2026 |
Recente toekomstige groei-updates
Recent updates
Narratiefupdate • Jun 01
507717: Share Buyback Will Support Future Upside Confidence
Analysts have slightly reduced their price target on Dhanuka Agritech, with fair value moving from about ₹1,439.57 to ₹1,414.38 as they update assumptions around revenue growth, profit margins and forward P/E multiples. What's in the News The board will meet on May 19, 2026, to consider audited financial results for the quarter and financial year ended March 31, 2026; introduce and consider Employee Stock Option Scheme 2026, Employee Stock Appreciation Rights 2026, and Restricted Stock Unit Plan 2026; and address other matters.Narratiefupdate • May 03
507717: Upcoming Director Appointment Will Support Future Upside Confidence
Analysts have nudged their price target on Dhanuka Agritech slightly higher, with fair value moving from ₹1,426.00 to about ₹1,439.57, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. What's in the News A postal ballot based Special or Extraordinary Shareholders Meeting is scheduled for March 19, 2026, in India (Key Developments).Narratiefupdate • Apr 18
507717: Upcoming Governance And Earnings Dates Will Support Future Upside Confidence
Analysts have trimmed their price target on Dhanuka Agritech slightly from ₹1,438.50 to ₹1,426.00, reflecting updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News Special or Extraordinary Shareholders Meeting scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (company filing).Narratiefupdate • Apr 03
507717: Upcoming Governance And Earnings Dates Will Support Upside Confidence
Analysts have kept their price target for Dhanuka Agritech steady at around ₹1,438, reflecting largely unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dhanuka Agritech has scheduled a Special or Extraordinary Shareholders Meeting via postal ballot in India on March 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (Key Developments).Narratiefupdate • Mar 19
507717: Upcoming Meetings Will Reinforce Confidence In Sustained Upside Potential
Analysts have kept the price target for Dhanuka Agritech broadly steady at around ₹1,438, with only minor model tweaks to the discount rate and the assumed future P/E driving the small change. What's in the News A Special or Extraordinary shareholders meeting is scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an independent director for a first term of 5 years (company filing).Narratiefupdate • Mar 05
507717: Upcoming Meetings Will Support Confidence In Long-Term Upside Potential
Analysts have maintained their ₹1,438.50 price target for Dhanuka Agritech and made only minor adjustments to their assumptions on discount rate, revenue growth, profit margin and future P/E. These limited changes suggest that their overall valuation framework remains broadly consistent with earlier assessments.
Nieuw narratief • Feb 21
Rural Distribution And Biostimulant Tailwinds Will Support A Stronger Long Term Outlook
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection and allied products to farmers across major agricultural regions in India. What are the underlying business or industry changes driving this perspective?Narratiefupdate • Feb 19
507717: Upcoming Board And Shareholder Meetings Will Support Long-Term Upside Potential
Analysts have revised their price target on Dhanuka Agritech from ₹1,571.75 to ₹1,438.50, reflecting updated assumptions around the discount rate, expected revenue growth, profit margin and future P/E multiples. What's in the News Dhanuka Agritech has scheduled a Board Meeting on Feb 05, 2026, at 13:00 Indian Standard Time to consider and approve the financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Nieuw narratief • Feb 06
Dahej Ramp Up Risks And Regulatory Setbacks Will Eventually Support A Stronger Business
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection products and related offerings to farmers across major agricultural regions. What are the underlying business or industry changes driving this perspective?Narratiefupdate • Feb 04
507717: Stable Assumptions And Upcoming Results Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,571.75, citing broadly consistent assumptions for the discount rate, revenue growth, profit margin and future P/E in their refreshed model. What's in the News Dhanuka Agritech has scheduled a board meeting on Feb 05, 2026.Narratiefupdate • Jan 21
507717: Higher Margin Outlook Will Support Long-Term Upside Potential
Analysts have trimmed their price target for Dhanuka Agritech by ₹35 to ₹1,571.75. This reflects updated views on slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to future P/E expectations, partly offset by a marginally higher profit margin outlook.Narratiefupdate • Jan 06
507717: Nagpur Plant Land Purchase Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,606.75, with only minor tweaks to inputs such as the discount rate, revenue growth, profit margin, and future P/E assumptions guiding their view. What's in the News Board meeting scheduled on Oct 31, 2025 at 11:00 Indian Standard Time to review and approve financial results for the quarter and half year ended Sep 30, 2025 (company filing).Narratiefupdate • Dec 16
507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential
Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple. What's in the News Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing) Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing) Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing) Valuation Changes The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.Narratiefupdate • Dec 02
507717: Upcoming Nagpur Plant And Board Actions Will Fuel Long-Term Momentum
Analysts have maintained their fair value estimate for Dhanuka Agritech at ₹1,638, citing stable projections for growth and profitability despite minor adjustments in underlying assumptions. What's in the News Dhanuka Agritech will hold a Board Meeting on October 31, 2025, at 11:00 Indian Standard Time (Board Meeting announcement).Narratiefupdate • Nov 17
507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion
Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.Narratiefupdate • Nov 03
507717: New Nagpur Plant And Higher Margins Will Drive Future Upside
Analysts have revised their price target for Dhanuka Agritech downward from ₹1,875 to ₹1,779.88. This adjustment reflects updated projections in revenue growth and profit margins, as well as a slightly reduced future valuation multiple.Narratiefupdate • Sep 05
Improved Monsoon Trends And Capacity Expansion Will Drive Agrochemicals Demand
With both the discount rate and future P/E essentially unchanged, analysts maintained Dhanuka Agritech’s fair value at ₹1875. What's in the News Board meeting scheduled to consider and approve financial results for the quarter ended 30 June, 2025.
Nieuw narratief • Feb 09
Acquiring Rights To Iprovalicarb And Triadimenol Will Open International Markets
International expansion and product innovation could boost revenue through new market entry, geographic diversification, and premium pricing for unique solutions.Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 3/31/2029 | 28,374 | N/A | N/A | N/A | 1 |
| 3/31/2028 | 25,978 | 3,531 | 2,465 | 3,176 | 7 |
| 3/31/2027 | 22,903 | 3,057 | 2,041 | 2,867 | 6 |
| 3/31/2026 | 20,198 | 2,872 | 1,685 | 1,962 | N/A |
| 12/31/2025 | 19,785 | 2,650 | N/A | N/A | N/A |
| 9/30/2025 | 20,138 | 2,800 | 714 | 2,663 | N/A |
| 6/30/2025 | 20,699 | 3,036 | N/A | N/A | N/A |
| 3/31/2025 | 20,352 | 2,970 | 687 | 2,627 | N/A |
| 12/31/2024 | 19,614 | 2,805 | N/A | N/A | N/A |
| 9/30/2024 | 19,194 | 2,708 | 985 | 1,431 | N/A |
| 6/30/2024 | 18,831 | 2,550 | N/A | N/A | N/A |
| 3/31/2024 | 17,585 | 2,391 | 451 | 1,345 | N/A |
| 12/31/2023 | 17,615 | 2,454 | N/A | N/A | N/A |
| 9/30/2023 | 17,516 | 2,461 | 1,061 | 2,317 | N/A |
| 6/30/2023 | 16,766 | 2,173 | N/A | N/A | N/A |
| 3/31/2023 | 17,002 | 2,335 | 120 | 1,362 | N/A |
| 12/31/2022 | 16,473 | 2,226 | N/A | N/A | N/A |
| 9/30/2022 | 16,108 | 2,191 | -640 | 331 | N/A |
| 6/30/2022 | 15,067 | 2,094 | N/A | N/A | N/A |
| 3/31/2022 | 14,778 | 2,089 | 445 | 1,043 | N/A |
| 12/31/2021 | 14,350 | 2,031 | N/A | N/A | N/A |
| 9/30/2021 | 13,738 | 2,007 | 792 | 1,038 | N/A |
| 6/30/2021 | 13,774 | 2,074 | N/A | N/A | N/A |
| 3/31/2021 | 13,875 | 2,106 | 2,184 | 2,311 | N/A |
| 12/31/2020 | 13,395 | 2,009 | N/A | N/A | N/A |
| 9/30/2020 | 13,153 | 1,886 | 2,589 | 2,726 | N/A |
| 6/30/2020 | 12,749 | 1,785 | N/A | N/A | N/A |
| 3/31/2020 | 11,201 | 1,413 | 1,484 | 1,621 | N/A |
| 12/31/2019 | 10,852 | 1,291 | N/A | N/A | N/A |
| 9/30/2019 | 10,305 | 1,160 | N/A | 627 | N/A |
| 6/30/2019 | 10,118 | 1,111 | N/A | N/A | N/A |
| 3/31/2019 | 10,058 | 1,126 | N/A | 133 | N/A |
| 12/31/2018 | 9,982 | 1,145 | N/A | N/A | N/A |
| 9/30/2018 | 10,029 | 1,285 | N/A | N/A | N/A |
| 6/30/2018 | 9,676 | 1,262 | N/A | N/A | N/A |
| 3/31/2018 | 9,626 | 1,262 | N/A | 1,377 | N/A |
| 12/31/2017 | 9,265 | 1,201 | N/A | N/A | N/A |
| 9/30/2017 | 9,168 | 1,183 | N/A | N/A | N/A |
| 6/30/2017 | 8,812 | 1,156 | N/A | N/A | N/A |
| 3/31/2017 | 8,833 | 1,219 | N/A | 631 | N/A |
| 12/31/2016 | 8,886 | 1,237 | N/A | N/A | N/A |
| 9/30/2016 | 8,857 | 1,196 | N/A | N/A | N/A |
| 6/30/2016 | 8,469 | 1,081 | N/A | N/A | N/A |
| 3/31/2016 | 8,289 | 1,073 | N/A | 1,397 | N/A |
| 12/31/2015 | 8,116 | 1,007 | N/A | N/A | N/A |
| 9/30/2015 | 7,850 | 1,002 | N/A | N/A | N/A |
| 6/30/2015 | 7,977 | 1,042 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 507717 ( 10.4% per jaar) ligt boven de spaarquote ( 6.9% ).
Winst versus markt: De winst van 507717 ( 10.4% per jaar) zal naar verwachting langzamer groeien dan de markt Indian ( 16.1% per jaar).
Hoge groeiwinsten: De winst van 507717 zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van 507717 ( 11.7% per jaar) zal naar verwachting sneller groeien dan de markt Indian ( 10.8% per jaar).
Hoge groei-inkomsten: De omzet van 507717 ( 11.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 507717 zal naar verwachting over 3 jaar laag zijn ( 16.5 %).
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/06/10 09:25 |
| Aandelenkoers aan het einde van de dag | 2026/06/10 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2026/03/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Dhanuka Agritech Limited wordt gevolgd door 17 analisten. 7 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |